• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchImmunotech Laboratories
    Picture of Immunotech Laboratories logo

    IMMB — Immunotech Laboratories Share News

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.11m
    • Enterprise Value
      $0.58m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • IMMB Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    IMMB Dividends
    • Ebola becomes latest stock scam, U.S. SEC says (updated)

      20/11/2014 21:53
    • Ebola becomes latest stock scam, U.S. SEC says (updated)

      20/11/2014 16:45
    • Ebola becomes latest stock scam, U.S. SEC says

      20/11/2014 15:46
    • Brief: SEC suspends trading in companies touting operations related to prevention or treatment of ebola

      20/11/2014 15:46
    • Brief: Immunotech Lab to market potential ebola treatment

      21/10/2014 13:07

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.